{
    "abstract": [],
    "body_text": [
        {
            "text": "Fatty acid biosynthesis (FAS) is one of the most important processes in cells and organisms on earth. ",
            "section": "Introduction"
        },
        {
            "text": "Fatty acids are essential for the cellular membrane assembly, energy storage, cell signal transduction and regulation of gene expression [1][2][3][4][5]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 137,
                    "end": 140,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "[1]"
                },
                {
                    "start": 140,
                    "end": 143,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2]"
                },
                {
                    "start": 143,
                    "end": 146,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "[3]"
                },
                {
                    "start": 146,
                    "end": 149,
                    "type": "bibr",
                    "ref_id": "b3",
                    "text": "[4]"
                },
                {
                    "start": 149,
                    "end": 152,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "[5]"
                }
            ]
        },
        {
            "text": "Deficiency in the FAS system causes delays in bacterial development and triggers programmed cell death in plants [2,3,6]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 113,
                    "end": 116,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2,"
                },
                {
                    "start": 116,
                    "end": 118,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "3,"
                },
                {
                    "start": 118,
                    "end": 120,
                    "type": "bibr",
                    "ref_id": "b5",
                    "text": "6]"
                }
            ]
        },
        {
            "text": "In human, deregulated FAS system has been correlated with metabolic syndrome (MetS) diseases, including obesity and type-II diabetes [7][8][9][10][11]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 133,
                    "end": 136,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "[7]"
                },
                {
                    "start": 136,
                    "end": 139,
                    "type": "bibr",
                    "ref_id": "b7",
                    "text": "[8]"
                },
                {
                    "start": 139,
                    "end": 142,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "[9]"
                },
                {
                    "start": 142,
                    "end": 146,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "[10]"
                },
                {
                    "start": 146,
                    "end": 150,
                    "type": "bibr",
                    "ref_id": "b10",
                    "text": "[11]"
                }
            ]
        },
        {
            "text": "Moreover, human fatty acid synthase (hFASN) has been considered as an oncogene because it is significantly overexpressed in several human cancers with poor prognosis and survival, particularly, including prostate and breast cancers [12][13][14][15][16][17].",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 232,
                    "end": 236,
                    "type": "bibr",
                    "ref_id": "b11",
                    "text": "[12]"
                },
                {
                    "start": 236,
                    "end": 240,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "[13]"
                },
                {
                    "start": 240,
                    "end": 244,
                    "type": "bibr",
                    "ref_id": "b13",
                    "text": "[14]"
                },
                {
                    "start": 244,
                    "end": 248,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "[15]"
                },
                {
                    "start": 248,
                    "end": 252,
                    "type": "bibr",
                    "ref_id": "b15",
                    "text": "[16]"
                },
                {
                    "start": 252,
                    "end": 256,
                    "type": "bibr",
                    "ref_id": "b16",
                    "text": "[17]"
                }
            ]
        },
        {
            "text": "The chemical logic of FAS system is highly conserved between eukaryotes and bacteria except for the arrangement of functional enzymatic modules. ",
            "section": "Introduction"
        },
        {
            "text": "It utilizes a series of enzymatic modules to iteratively carry out fatty acid elongation, which is divided into two stages: synthesis initiation and elongation ( Figure 1). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 162,
                    "end": 170,
                    "type": "figure",
                    "text": "Figure 1"
                }
            ]
        },
        {
            "text": "The initiation stage covalently attaches a short acetyl (or malonyl) group to the terminal sulfhydryl of the 4-phosphopantetheine arm (4\u2032-Pan-arm, hereafter) on the substrate carrier protein, which is a holo-acyl carrier protein (holo-ACP). ",
            "section": "Introduction"
        },
        {
            "text": "Subsequently, ACP shuttles among approximately four enzymatic modules in the elongation cycle to process fatty acid extension; and two additional carbons are added to the substrate chain in each cycle until the product is released. ",
            "section": "Introduction"
        },
        {
            "text": "On the basis of the enzymatic module arrangement, the FAS system is divided into associative and dissociative architectural types. ",
            "section": "Introduction"
        },
        {
            "text": "The associative architecture (FAS-I) exists in some bacteria (e.g., CMN-FAS) and eukaryotes, including mammals and fungi [1,18]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 121,
                    "end": 124,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "[1,"
                },
                {
                    "start": 124,
                    "end": 127,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "18]"
                }
            ]
        },
        {
            "text": "All the enzymatic modules function as domains on a large polypeptide (one or two polypeptide(s) in fungi), which is encoded by a single gene (one or two gene(s) in fungi). ",
            "section": "Introduction"
        },
        {
            "text": "The dissociative architecture (FAS-II) exists in plants, mitochondria and bacteria, whereas the enzymatic modules function as a series of individual soluble enzymes encoded by discrete genes [2]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 191,
                    "end": 194,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2]"
                }
            ]
        },
        {
            "text": "So far, crystal structures of FAS-I synthases (FASN) from Sus scrofa and fungi [19][20][21][22][23] and FAS-II individual enzymes from various bacterial species have been reported [2,[24][25][26][27][28], which provided detailed insights into the biochemical mechanism at an atomic level. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 79,
                    "end": 83,
                    "type": "bibr",
                    "ref_id": "b18",
                    "text": "[19]"
                },
                {
                    "start": 83,
                    "end": 87,
                    "type": "bibr",
                    "ref_id": "b19",
                    "text": "[20]"
                },
                {
                    "start": 87,
                    "end": 91,
                    "type": "bibr",
                    "ref_id": "b20",
                    "text": "[21]"
                },
                {
                    "start": 91,
                    "end": 95,
                    "type": "bibr",
                    "ref_id": "b21",
                    "text": "[22]"
                },
                {
                    "start": 95,
                    "end": 99,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "[23]"
                },
                {
                    "start": 180,
                    "end": 183,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2,"
                },
                {
                    "start": 183,
                    "end": 187,
                    "type": "bibr",
                    "ref_id": "b23",
                    "text": "[24]"
                },
                {
                    "start": 187,
                    "end": 191,
                    "type": "bibr",
                    "ref_id": "b24",
                    "text": "[25]"
                },
                {
                    "start": 191,
                    "end": 195,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[26]"
                },
                {
                    "start": 195,
                    "end": 199,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "[27]"
                },
                {
                    "start": 199,
                    "end": 203,
                    "type": "bibr",
                    "ref_id": "b27",
                    "text": "[28]"
                }
            ]
        },
        {
            "text": "However, due to the high flexibility and diffusible characteristics of ACP, the interactions between ACP and enzyme modules in FASN or individual enzymes in FAS-II have rarely been investigated except for an incomplete enoyl reductase (FabI)-ACP structure and a covalently crosslinked \u03b2-hydroxyacyl-ACP dehydratase (FabA)-ACP structure [25,29]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 336,
                    "end": 340,
                    "type": "bibr",
                    "ref_id": "b24",
                    "text": "[25,"
                },
                {
                    "start": 340,
                    "end": 343,
                    "type": "bibr",
                    "ref_id": "b28",
                    "text": "29]"
                }
            ]
        },
        {
            "text": "Hence, the key mechanisms underlying the recognition and processing of ACP by enzymatic modules for substrate catalysis remain unclear, especially in the elongation cycle.",
            "section": "Introduction"
        },
        {
            "text": "The elongation cycle predominantly consists of four catalytic steps (Figure 1). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 68,
                    "end": 77,
                    "type": "figure",
                    "text": "(Figure 1"
                }
            ]
        },
        {
            "text": "Dehydration of \u03b2-hydroxyacyl-ACP is the third step, which is processed either by the dehydratase (DH) domain of FAS-I synthase or two individual DH homologs, FabA and FabZ, in FAS-II ( Figure 1) [1,2]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 185,
                    "end": 193,
                    "type": "figure",
                    "text": "Figure 1"
                },
                {
                    "start": 195,
                    "end": 198,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "[1,"
                },
                {
                    "start": 198,
                    "end": 200,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "2]"
                }
            ]
        },
        {
            "text": "FabA appears as a homodimer and catalyzes the dehydration of short fatty acids (\u2264 10-carbon) as well as the isomerization of trans-2-acyl-ACP to cis-2-acyl-ACP. ",
            "section": "Introduction"
        },
        {
            "text": "In contrast, FabZ appears as a hexamer in Figure 1 Schematic diagram of fatty acid biosynthesis process. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 42,
                    "end": 50,
                    "type": "figure",
                    "text": "Figure 1"
                }
            ]
        },
        {
            "text": "The catalytic process is divided into initiation and elongation stages. ",
            "section": "Introduction"
        },
        {
            "text": "In the initiation stage, apo-form of acyl carrier protein (apo-ACP, green) is covalently installed with a 4\u2032-phosphopantetheine moiety (4\u2032-Pan-arm) by holo-ACP synthase (AcpS), forming holo-ACP. ",
            "section": "Introduction"
        },
        {
            "text": "Subsequently, a short acetyl (or malonyl) group is covalently attached to the terminal sulfhydryl of the 4\u2032-Pan-arm by malonyl-CoA-/acetyl-CoA-ACP transacylase (MAT domain in FAS-I; FabD in FAS-II). ",
            "section": "Introduction"
        },
        {
            "text": "The elongation cycle mainly includes four catalytic steps to process fatty acid extension successively. ",
            "section": "Introduction"
        },
        {
            "text": "The first step is decarboxylative condensation to form \u03b2-ketoacyl-ACP by \u03b2-ketoacyl synthase (KS domain in FAS-I; FabH, FanB and FabF in FAS-II); the second step is NADPH-dependent reduction of \u03b2-ketoacyl-ACP to \u03b2-hydroxyacyl-ACP by \u03b2-ketoacyl reductase (KR domain in FAS-I; FabG in FAS-II); the third step is \u03b2-hydroxyacyl-ACP dehydration to \u03b2-enoyl-ACP by \u03b2-hydroxyacyl-ACP dehydratase (DH domain in FAS-I; FabA and FabZ in FAS-II); the last step is \u03b2-enoyl-ACP reduction by NADPH-dependent \u03b2-enoyl reductase (ER domain in FAS-I; FabI, FabK and FabL in FAS-II). ",
            "section": "Introduction"
        },
        {
            "text": "After four steps, two carbons are added to the fatty acid chain, and the fatty acid chain either re-enter the elongation cycle for further extension or is released from ACP by thioesterase (TE domain in FAS-I; TE in FAS-II) once the length reaches 16-18 carbons. ",
            "section": "Introduction"
        },
        {
            "text": "most cases (dimer is also observed besides hexamer in Plasmodium falciparum) and preferentially catalyzes the dehydration of long-chain fatty acids [2] (Supplementary information, Figure S1). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 148,
                    "end": 151,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2]"
                },
                {
                    "start": 180,
                    "end": 189,
                    "type": "figure",
                    "text": "Figure S1"
                }
            ]
        },
        {
            "text": "In addition, FabZ is involved in the balance maintenance of fatty acid and lipid A biosynthesis by regulating deacetylase LpxC [30]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 127,
                    "end": 131,
                    "type": "bibr",
                    "ref_id": "b29",
                    "text": "[30]"
                }
            ]
        },
        {
            "text": "Due to their indispensable functions and ubiquitous distributions, FabA and FabZ are regarded as important drug targets against pathogenic microbes. ",
            "section": "Introduction"
        },
        {
            "text": "The enzymatic characteristics of FabA and FabZ, as well as their structures in various bacterial species have been well studied, and several lead compounds have been developed [31][32][33][34][35]. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 176,
                    "end": 180,
                    "type": "bibr",
                    "ref_id": "b30",
                    "text": "[31]"
                },
                {
                    "start": 180,
                    "end": 184,
                    "type": "bibr",
                    "ref_id": "b31",
                    "text": "[32]"
                },
                {
                    "start": 184,
                    "end": 188,
                    "type": "bibr",
                    "ref_id": "b32",
                    "text": "[33]"
                },
                {
                    "start": 188,
                    "end": 192,
                    "type": "bibr",
                    "ref_id": "b33",
                    "text": "[34]"
                },
                {
                    "start": 192,
                    "end": 196,
                    "type": "bibr",
                    "ref_id": "b34",
                    "text": "[35]"
                }
            ]
        },
        {
            "text": "In 2014, Nguyen et al. ",
            "section": "Introduction"
        },
        {
            "text": "[29] reported the first FabA-ACP complex structure, in which a mechanism-based synthetic alkyne probe was employed to covalently crosslink two ACP molecules to the FabA homodimer. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b28",
                    "text": "[29]"
                }
            ]
        },
        {
            "text": "The complex structure reveals ACP binding and the substrate accommodation mechanism of FabA for the first time. ",
            "section": "Introduction"
        },
        {
            "text": "A putative ACP binding mechanism was proposed based on the significant conformational changes of ACP helices \u03b12 and \u03b13 observed during binding to FabA. ",
            "section": "Introduction"
        },
        {
            "text": "Nevertheless, this structural model has not provided adequate insights into how the DH module recognizes and regulates ACP molecules for enzymatic catalysis in the FAS system and what determines the distinct substrate length preference and isomerization mechanism between FabA and FabZ. ",
            "section": "Introduction"
        },
        {
            "text": "The DH module (FabZ)-ACP complex structure in the FAS system presented in current study illustrates a dynamic seesaw-like ACP binding and regulation mechanism of FabZ, representing a novel substrate selection and catalysis mechanism for the DH module in the FAS system.",
            "section": "Introduction"
        },
        {
            "text": "The recombinant FabZ and ACP from Helicobacter pylori were expressed and purified as described previously [36,37]. ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 106,
                    "end": 110,
                    "type": "bibr",
                    "ref_id": "b35",
                    "text": "[36,"
                },
                {
                    "start": 110,
                    "end": 113,
                    "type": "bibr",
                    "ref_id": "b36",
                    "text": "37]"
                }
            ]
        },
        {
            "text": "Instead of using an alkyne probe attached to ACP (which was used in FabA-ACP structure [29]), holo-ACP was directly employed in crystallization to obtain the natural conformation of the DH module bound with ACP. ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 87,
                    "end": 91,
                    "type": "bibr",
                    "ref_id": "b28",
                    "text": "[29]"
                }
            ]
        },
        {
            "text": "The purified FabZ and holo-ACP proteins were mixed with a molar ratio of 1:7, and further purified by using Superdex 200 gel-filtration column. ",
            "section": "Overall structure of the FabZ-ACP complex"
        },
        {
            "text": "The crystals appeared within 30 days under 277 K in hanging drop, and the complex structure was determined by molecular replacement (MR) at a resolution of 2.55 \u00c5 (Supplementary information, Table S1). ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 191,
                    "end": 199,
                    "type": "table",
                    "text": "Table S1"
                }
            ]
        },
        {
            "text": "The asymmetric crystallographic unit contains a FabZ dimer subunit bound with a holo-ACP molecule. ",
            "section": "Overall structure of the FabZ-ACP complex"
        },
        {
            "text": "However, the gel-filtration results indicated that the complex appears to have a stable hexamer conformation that reflects native FabZ in complex with ACP (Supplementary information, Figure S2). ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 183,
                    "end": 193,
                    "type": "bibr",
                    "text": "Figure S2)"
                }
            ]
        },
        {
            "text": "As shown in Figure 2A, the overall structure of the FabZ-ACP hexamer generated by crystallographic symmetry operation displays a turbine-like shape with six FabZ monomers arranged in a ring-like contact topology to form a classic FabZ \"trimer of dimers\" hexameric turbine core [26]. ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 12,
                    "end": 21,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2A"
                },
                {
                    "start": 277,
                    "end": 281,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[26]"
                }
            ]
        },
        {
            "text": "Each FabZ dimer subunit is bound by one holo-ACP, resulting in a stoichiometry of (FabZ dimer-ACP) 3 .",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 99,
                    "end": 100,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "3"
                }
            ]
        },
        {
            "text": "In the dimer subunit, an unexpected 2:1 (FabZ monomer:ACP) stoichiometric binding ratio is observed, where only one ACP molecule binds to a FabZ dimer. ",
            "section": "Overall structure of the FabZ-ACP complex"
        },
        {
            "text": "FabZ monomers A and B within the dimer subunit adopt a typical \u03b2 + \u03b1 \"hot dog\" fold in which a layer consisting of six anti-parallel \u03b2-sheets (\u03b21-\u03b26 strands, hereafter) wraps around the long, central six-turn \u03b1-helix (\u03b13) (Figure 2B)  [2,26]. ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 222,
                    "end": 233,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "(Figure 2B)"
                },
                {
                    "start": 235,
                    "end": 238,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2,"
                },
                {
                    "start": 238,
                    "end": 241,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "26]"
                }
            ]
        },
        {
            "text": "The \u03b2-sheet layer from each monomer further interacts with each other through their \u03b23 strands to form a stable FabZ homodimer subunit. ",
            "section": "Overall structure of the FabZ-ACP complex"
        },
        {
            "text": "Next to the dimer interface, there are two L-shaped substrate-binding and catalysis tunnels, which are ~20 \u00c5 away from each other. ",
            "section": "Overall structure of the FabZ-ACP complex"
        },
        {
            "text": "Each tunnel consists of residues from both monomers. ",
            "section": "Overall structure of the FabZ-ACP complex"
        },
        {
            "text": "The entrance of the tunnel is located on the \u03b23 strand near the dimer interface, and protected by a gatekeeper residue Tyr100 from bulk solvent. ",
            "section": "Overall structure of the FabZ-ACP complex"
        },
        {
            "text": "Here we named the two tunnels of the dimer subunit tunnels A (the gatekeeper residue Tyr100 is from monomer A) and B (Tyr100 is from monomer B). ",
            "section": "Overall structure of the FabZ-ACP complex"
        },
        {
            "text": "The holo-ACP binds to the \u03b2-sheet layer right on the FabZ dimer interface through its conserved \u03b12 helix, occupying the monomer A and B surface areas of 148.82 \u00c5 2 and 335.03 \u00c5 2 , respectively, and inserts the 4\u2032-Pan-arm into tunnel B ( Figure 2B). ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 238,
                    "end": 247,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2B"
                }
            ]
        },
        {
            "text": "The FabZ-ACP interactions are established through multiple hydrogen bonds (H-bonds) between a list of conserved residues, including those between positively charged residue Arg110\u2032 on FabZ \u03b23 strand (the prime indicates the residue from FabZ monomer A in the dimer, otherwise from monomer B) and two negatively charged residues Asp35 and Asp38 on the N-terminus of ACP \u03b12 helix, between Lys129 on the loop between FabZ \u03b24 and \u03b25 strands and Glu47 on the C-terminus of ACP \u03b12 helix, and between Lys152 on FabZ \u03b26 strand and Glu41 on the C-terminus of ACP \u03b12 helix ( Figure 2B, Supplementary information, Figures S3, S4 and Table S2). ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 565,
                    "end": 574,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2B"
                },
                {
                    "start": 603,
                    "end": 617,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figures S3, S4"
                },
                {
                    "start": 622,
                    "end": 630,
                    "type": "table",
                    "text": "Table S2"
                }
            ]
        },
        {
            "text": "In addition to H-bonds, the sidechains of Leu37, Val40 and Met44 on ACP \u03b12 helix form hydrophobic contacts with the hydrophobic patch composed of Met102, Thr103, Ile132 and Lys152 from FabZ ( Figure 2B). ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 192,
                    "end": 201,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2B"
                }
            ]
        },
        {
            "text": "These hydrophobic and electrostatic interactions orient the ACP \u03b12 helix precisely with the entrance of the FabZ tunnel B. Meanwhile, the sidechain of the gatekeeper residue Tyr100 in  conformation so that the ACP 4\u2032-Pan-arm can comfortably enter tunnel B ( Figure 2B). ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 258,
                    "end": 267,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2B"
                }
            ]
        },
        {
            "text": "Inside tunnel B, the arm displays a nearly extended conformation (Supplementary information, Figure S5). ",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 93,
                    "end": 102,
                    "type": "figure",
                    "text": "Figure S5"
                }
            ]
        },
        {
            "text": "The conformation is stabilized by H-bonds between the backbone oxygen of Arg110\u2032 from FabZ and ACP 4\u2032-Pan-arm hydroxyl group (atom O 33 ) and the first -NH group (atom N 36 ) ( Figure 2B), which indicates that the role of Arg110 in ACP binding is indispensable, consistent with results from previous reports [2,38].",
            "section": "Overall structure of the FabZ-ACP complex",
            "ref_spans": [
                {
                    "start": 177,
                    "end": 186,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2B"
                },
                {
                    "start": 308,
                    "end": 311,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2,"
                },
                {
                    "start": 311,
                    "end": 314,
                    "type": "bibr",
                    "ref_id": "b37",
                    "text": "38]"
                }
            ]
        },
        {
            "text": "Previous studies indicate that the L-shaped FabZ active tunnel is not adequate for accommodating a long fatty acid substrate (> 12-carbon), although FabZ enzymatically prefers long substrates [2,[26][27][28]. ",
            "section": "Fatty acyl chain length preference of FabZ",
            "ref_spans": [
                {
                    "start": 192,
                    "end": 195,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2,"
                },
                {
                    "start": 195,
                    "end": 199,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[26]"
                },
                {
                    "start": 199,
                    "end": 203,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "[27]"
                },
                {
                    "start": 203,
                    "end": 207,
                    "type": "bibr",
                    "ref_id": "b27",
                    "text": "[28]"
                }
            ]
        },
        {
            "text": "In the current structure, ACP binding and insertion of the 4\u2032-Pan-arm expand the active tunnel by pushing the \u03b2-sheet layer toward \u03b24 ( Figure 3A), which evokes a novel Y-shaped tunnel with extended potential for long fatty acid accommodation. ",
            "section": "Fatty acyl chain length preference of FabZ",
            "ref_spans": [
                {
                    "start": 136,
                    "end": 145,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 3A"
                }
            ]
        },
        {
            "text": "The extension of the classical L-shaped tunnel B starts around residue Gly79 by forming two tunnel branches (designated tunnels I and II; Figure 4A). ",
            "section": "Fatty acyl chain length preference of FabZ",
            "ref_spans": [
                {
                    "start": 138,
                    "end": 147,
                    "type": "figure",
                    "ref_id": "fig_3",
                    "text": "Figure 4A"
                }
            ]
        },
        {
            "text": "Tunnel I consists of hydrophobic residues Gly78, Gly79, Trp133, Val135, Leu151 and Ala153 ( Figure 4B), whereas tunnel II consists of hydrophobic residues Leu21, Phe83, Ile93, Ala94, Lys97 and Ile98 from monomer B ( Figure 4C). ",
            "section": "Fatty acyl chain length preference of FabZ",
            "ref_spans": [
                {
                    "start": 92,
                    "end": 101,
                    "type": "figure",
                    "ref_id": "fig_3",
                    "text": "Figure 4B"
                },
                {
                    "start": 216,
                    "end": 225,
                    "type": "figure",
                    "ref_id": "fig_3",
                    "text": "Figure 4C"
                }
            ]
        },
        {
            "text": "Accordingly, the hydrophobic nature of both tunnels I and II is suitable for accommodation of fatty acids.",
            "section": "Fatty acyl chain length preference of FabZ"
        },
        {
            "text": "To investigate the selectivity of two tunnels for different lengths of fatty acid substrates, we docked 4-, 6-, 8-, 10-, 12-, 14-and 16-carbon fatty acid chains into the active tunnel structure (Supplementary information, Table  S3) [39]. ",
            "section": "Fatty acyl chain length preference of FabZ",
            "ref_spans": [
                {
                    "start": 222,
                    "end": 231,
                    "type": "table",
                    "text": "Table  S3"
                },
                {
                    "start": 233,
                    "end": 237,
                    "type": "bibr",
                    "ref_id": "b38",
                    "text": "[39]"
                }
            ]
        },
        {
            "text": "As shown in Figure 4, short fatty acid chains (4-, 6-, 8-, 10-and 12-carbon chains) extend to tunnel I, whereas tunnel II is blocked by the sidechain of Phe83 (closed conformation, pointing toward Ile98). ",
            "section": "Fatty acyl chain length preference of FabZ",
            "ref_spans": [
                {
                    "start": 12,
                    "end": 20,
                    "type": "figure",
                    "ref_id": "fig_3",
                    "text": "Figure 4"
                }
            ]
        },
        {
            "text": "In contrast, longer fatty acid chains (14-and 16-carbon chains) extend to tunnel II by switching the sidechain of Phe83 toward Ile93 to form an open conformation [26]. ",
            "section": "Fatty acyl chain length preference of FabZ",
            "ref_spans": [
                {
                    "start": 162,
                    "end": 166,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[26]"
                }
            ]
        },
        {
            "text": "Notably, the exit of tunnel II is a loop area between \u03b23 and \u03b14 (residues Ala94-Lys97), which was reported to be disordered in previously determined FabZ structures [27,28], suggesting that this exit has flexibility and compatibility for threading out long substrates.",
            "section": "Fatty acyl chain length preference of FabZ",
            "ref_spans": [
                {
                    "start": 165,
                    "end": 169,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "[27,"
                },
                {
                    "start": 169,
                    "end": 172,
                    "type": "bibr",
                    "ref_id": "b27",
                    "text": "28]"
                }
            ]
        },
        {
            "text": "The FabZ dimer shares high structural similarity with the FabA dimer. ",
            "section": "Distinct isomerization behavior between FabA and FabZ"
        },
        {
            "text": "Nevertheless, unlike FabA, FabZ does not function as an isomerase [2]. ",
            "section": "Distinct isomerization behavior between FabA and FabZ",
            "ref_spans": [
                {
                    "start": 66,
                    "end": 69,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2]"
                }
            ]
        },
        {
            "text": "Comparison of the structures of FabZ-ACP and FabA-ACP complexes, both docked with an 8-carbon trans-2 fatty acid chain, shows that the ACP 4\u2032-Pan-arms adopt a similar conformation in the two structures, whereas the conformation of the fatty acid substrate appears to be significantly different (Supplementary information, Figure S6). ",
            "section": "Distinct isomerization behavior between FabA and FabZ",
            "ref_spans": [
                {
                    "start": 322,
                    "end": 331,
                    "type": "figure",
                    "text": "Figure S6"
                }
            ]
        },
        {
            "text": "The carbon chain displays a nearly U-shape conformation in FabZ tunnel I compared with the L-shape in FabA because the tunnel leading to a U-shape in FabA is blocked by Val90 and Val162. ",
            "section": "Distinct isomerization behavior between FabA and FabZ"
        },
        {
            "text": "Interestingly, the fatty acid chain adopts a cis conformation in FabA, whereas it remains the trans configuration in FabZ, which is consistent with a hypothesis proposed by Kimber et al. ",
            "section": "Distinct isomerization behavior between FabA and FabZ"
        },
        {
            "text": "[27] that the L-shape tunnel has much less steric hindrance for the carbonyl chain isomerization compared with the U-shape.",
            "section": "Distinct isomerization behavior between FabA and FabZ",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "[27]"
                }
            ]
        },
        {
            "text": "Unlike two ACPs covalently binding to the FabA dimer, only one ACP binds to the FabZ dimer subunit. ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ"
        },
        {
            "text": "The superposition of holo-ACP from the FabZ-ACP complex with native apo-and holo-ACP structures displays high structural similarity except for the 4\u2032-Pan-arm orientation (Supplementary information, Figure S7), suggesting that the conformation of ACP itself does not interfere with the stoichiometric binding. ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 198,
                    "end": 207,
                    "type": "figure",
                    "text": "Figure S7"
                }
            ]
        },
        {
            "text": "In contrast, significant conformational changes in both FabZ monomers were observed. ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ"
        },
        {
            "text": "In FabZ monomer B, the anti-parallel \u03b2-sheet layer moves ~2.8 \u00c5 toward \u03b24 due to ACP binding and 4\u2032-Panarm insertion ( Figure 3A). ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 119,
                    "end": 129,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 3A)"
                }
            ]
        },
        {
            "text": "The narrow L-shaped active tunnel is, therefore, expanded to a Y-shape to accommodate a long fatty acid substrate. ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ"
        },
        {
            "text": "In addition, the phenol ring of Tyr100 sidechain points toward Lys62\u2032 to allow the 4\u2032-Pan-arm inserting into the catalytic tunnel ( Figure  3C). ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 132,
                    "end": 143,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure  3C)"
                }
            ]
        },
        {
            "text": "Surprisingly, FabZ monomer A also has similar conformational changes upon ACP binding to monomer B. The \u03b2-sheet layer in monomer A moves 1.0-1.7 \u00c5 farther toward \u03b24 compared with that in monomer B and the specific loop between \u03b24 and \u03b25 is extruded by a distance of ~4.8 \u00c5 ( Figure 3B). ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 275,
                    "end": 284,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 3B"
                }
            ]
        },
        {
            "text": "The extruded loop introduces clashes into most of interactions between the \u03b2-sheet layer of FabZ and ACP \u03b12 helix, especially the hydrophobic contacts between FabZ Lys129\u2032 and Glu47/Glu53 from ACP, as well as FabZ Ile132\u2032 and Val40/Met44 from ACP (Supplementary information, Figure S8), forming a conformation unfavorable for ACP binding. ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 275,
                    "end": 284,
                    "type": "figure",
                    "text": "Figure S8"
                }
            ]
        },
        {
            "text": "To support such conformational movements, the Tyr100\u2032 sidechain adopts an abnormal closed conformation by further rotating ~30\u00b0 clockwise along the C \u03b1 -C bond from the regular closed conformation (in the native FabZ hexamer structure [26]) and pointing toward the backbone carbonyl oxygen of Phe109 to generate additional H-bond ( Figure  3D). ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 235,
                    "end": 239,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[26]"
                },
                {
                    "start": 332,
                    "end": 342,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure  3D"
                }
            ]
        },
        {
            "text": "These structural observations strongly argue that FabZ regulates ACP binding and releasing through alternating movements of the \u03b2-sheet layer.",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ"
        },
        {
            "text": "Indeed, these \u03b2-sheet layer movements have been observed in our previous study of the native FabZ structure, in which three monomers (defined as monomers A-C) adopt a close conformation, while the other three (monomers D-E) adopt an open conformation [26]. ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 251,
                    "end": 255,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[26]"
                }
            ]
        },
        {
            "text": "These movements directly correlated with the sidechain position of the gatekeeper residue Tyr100. ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ"
        },
        {
            "text": "Tyr100 is located on the \u03b23 strand next to the active tunnel entrance and adopts two distinct conformations in the native FabZ hexamer structure either by pointing the phenol ring toward Lys62\u2032 to form an open conformation (the tunnel entrance is opened to substrate; e.g., monomer E) or rotating the phenol ring along the C \u03b1 -C \u03b2 bond for ~120\u00b0 to interact with Pro112\u2032 to form a closed conformation (the tunnel entrance is blocked by the sidechain of Tyr100; e.g., monomer A) ( Figure 3E). ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 481,
                    "end": 490,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 3E"
                }
            ]
        },
        {
            "text": "In the native FabZ hexamer structure, the hydrophobic interaction between the Tyr100 sidechain and Pro112\u2032 in the closed conformation pushes the \u03b2-sheet layer further toward \u03b24 compared with the open conformation ( Figure 3E). ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 215,
                    "end": 224,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 3E"
                }
            ]
        },
        {
            "text": "In the FabZ-ACP complex structure, the abnormal conformation of Tyr100\u2032 sidechain further pushes the \u03b2-sheet layer toward \u03b24 ( Figure 3D), likely causing ACP releasing. ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 127,
                    "end": 136,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 3D"
                }
            ]
        },
        {
            "text": "Previous studies suggested that the gatekeeper residue commonly exists in the DH across species in the FAS system for protecting the hydrophobic catalytic tunnel from bulk solvent [2,27,28]. ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 180,
                    "end": 183,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2,"
                },
                {
                    "start": 183,
                    "end": 186,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "27,"
                },
                {
                    "start": 186,
                    "end": 189,
                    "type": "bibr",
                    "ref_id": "b27",
                    "text": "28]"
                }
            ]
        },
        {
            "text": "Multiple sequence alignments of FabZ among 72 bacterial species indicate that tyrosine is the predominant gatekeeper (61%), whereas some other residues with hydrophobic sidechains, such as phenylalanine (22%) and leucine (17%), are also observed (Supplementary information, Figure S3C). ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 274,
                    "end": 284,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure S3C"
                }
            ]
        },
        {
            "text": "Our studies suggest that the absence of the Tyr100 sidechain in FabZ Y100A mutant completely abolishes the move-ments of the \u03b2-sheet layer within the FabZ hexamer ( Figure 3F) and significantly reduces FabZ enzymatic activity to ~10% by interfering with the release of ACP [26]. ",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ",
            "ref_spans": [
                {
                    "start": 165,
                    "end": 174,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 3F"
                },
                {
                    "start": 273,
                    "end": 277,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[26]"
                }
            ]
        },
        {
            "text": "Together with structural observations, these results indicate that the hydrophobic sidechain of such a gatekeeper is indispensable for the maintenance of FabZ enzymatic activity not only for simply protecting the hydrophobic catalytic tunnel from bulk solvent but also for regulating ACP binding and releasing by rotating its sidechain to manipulate the movements of the \u03b2-sheet layer in an alternating manner like a seesaw.",
            "section": "The dynamic seesaw-like catalytic mechanism of FabZ"
        },
        {
            "text": "The structural packing analysis indicates that the N-terminus of holo-ACP from the crystallographic neighbor FabZ-ACP molecule has contacts with the ACP-unbound FabZ monomer A to form a potential large tetramer complex with a stoichiometry of (FabZ hexamer-ACP 3 ) 4 or an even larger aggregated mass due to the linkage effect (Supplementary information, Figure S9). ",
            "section": "Biophysical studies of FabZ-ACP binding",
            "ref_spans": [
                {
                    "start": 355,
                    "end": 364,
                    "type": "figure",
                    "text": "Figure S9"
                }
            ]
        },
        {
            "text": "To investigate whether the crystal packing force from the neighbor ACP molecule contributes to the conformational changes in monomer A observed in our crystal structure, we carefully examined the contacts between monomer A and the neighbor ACP. ",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "The contacts are contributed by hydrophobic interactions between the sidechains of Met102\u2032 and Met154\u2032 from FabZ monomer A and the backbones of a cloning-generated extra residue Gly(-2) at the N-terminus of ACP, as well as the sidechain of Arg110 from FabZ monomer B and the sidechain of another cloning-generated extra residue Tyr(-1) of ACP (Supplementary information, Figure  S9A and S9B). ",
            "section": "Biophysical studies of FabZ-ACP binding",
            "ref_spans": [
                {
                    "start": 371,
                    "end": 382,
                    "type": "figure",
                    "text": "Figure  S9A"
                }
            ]
        },
        {
            "text": "Among the interactions, Tyr100\u2032 from FabZ monomer A interacts weakly through its hydroxyl group to the backbone N atom of ACP Ser(-4) residue (~4.0 \u00c5 distance). ",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "As Ser(-4) is the very first residue at the N-terminus of ACP, the interaction between Ser(-4) and Tyr100 is even weaker than normal hydrophobic interaction due to the high flexibility of the residue. ",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "The superposition of FabZ monomers A and B suggests that the sidechains of Met102 and Met154 are slightly bended, and the sidechain of Arg110 is extended due to the packing forces (Supplementary information, Figure S9C and S9D). ",
            "section": "Biophysical studies of FabZ-ACP binding",
            "ref_spans": [
                {
                    "start": 208,
                    "end": 218,
                    "type": "figure",
                    "text": "Figure S9C"
                }
            ]
        },
        {
            "text": "Obviously, the packing forces tend to push the sidechain of Tyr100\u2032 from monomer A anticlockwise, forming an open conformation rather than the current \"super-close\" conformation, and push the \u03b2-sheet layer to move backward rather than toward \u03b24. ",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "Hence, the crystal packing has little influence on the observed conformational changes in monomer A in the complex structure.",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "As these interactions, potentially induced by crystallographic packing, occur close to the entrance of FabZ tunnel A, steric hindrance of the neighbor holo-ACP may block the FabZ tunnel entrance, thus preventing the binding of a second holo-ACP in solution (Supplementary information, Figure S2). ",
            "section": "Biophysical studies of FabZ-ACP binding",
            "ref_spans": [
                {
                    "start": 285,
                    "end": 294,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure S2"
                }
            ]
        },
        {
            "text": "To eliminate this concern, the oligomeric state of the FabZ-ACP complex in solution was evaluated by size-exclusion chromatography coupled with multi-angle light scattering (SEC-MALS). ",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "Compared with native FabZ, the molecular weight of the complex is almost exactly that of a FabZ hexamer plus three holo-ACPs ( Figure 5A and 5B). ",
            "section": "Biophysical studies of FabZ-ACP binding",
            "ref_spans": [
                {
                    "start": 127,
                    "end": 144,
                    "type": "figure",
                    "text": "Figure 5A and 5B)"
                }
            ]
        },
        {
            "text": "The stoichiometry was further confirmed by synchrotron-based small-angle X-ray scattering (SAXS) ( Figure 5C-5E). ",
            "section": "Biophysical studies of FabZ-ACP binding",
            "ref_spans": [
                {
                    "start": 99,
                    "end": 112,
                    "type": "figure",
                    "text": "Figure 5C-5E)"
                }
            ]
        },
        {
            "text": "The low-resolution particle model reconstructed from the SAXS experimental profiles fits well with the respective complex structure (\u03c7 2 = 0.922), which suggests that the FabZ-ACP complex adopts the same stoichiometry in solution as observed in the crystal structure. ",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "Subsequently, a titration-based microscale thermophoresis assay (MST) was employed to identify the binding affinities of holo-ACP to FabZ (Figure 5F and 5G) [40]. ",
            "section": "Biophysical studies of FabZ-ACP binding",
            "ref_spans": [
                {
                    "start": 138,
                    "end": 148,
                    "type": "figure",
                    "text": "(Figure 5F"
                },
                {
                    "start": 157,
                    "end": 161,
                    "type": "bibr",
                    "ref_id": "b39",
                    "text": "[40]"
                }
            ]
        },
        {
            "text": "On the basis of the stoichiometry, the binding curve appears in triphasic phases with binding affinities of 0.354 \u00b1 0.056, 16.2 \u00b1 1.5 and 297 \u00b1 22.1 \u00b5M ( Figure 5F). ",
            "section": "Biophysical studies of FabZ-ACP binding",
            "ref_spans": [
                {
                    "start": 154,
                    "end": 163,
                    "type": "figure",
                    "text": "Figure 5F"
                }
            ]
        },
        {
            "text": "The distinct binding affinities also indicate that the binding of ACP to FabZ hexamer involves a complicated allosteric crosstalk, not only between monomers within a FabZ dimer subunit observed from the structure, but also between dimers within the FabZ hexamer. ",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "It is likely that the binding of each ACP induces significant conformational changes of ACP-unbound and -bound FabZ dimer subunits, thus influencing the subsequent ACP binding (lower binding affinities). ",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "Such conformational changes are most likely regulated by the gatekeeper residue Tyr100, as ACP binding as well as FabZ enzymatic activity are abolished by FabZ Y100A mutagenesis ( Figure 5G) [40]. ",
            "section": "Biophysical studies of FabZ-ACP binding",
            "ref_spans": [
                {
                    "start": 180,
                    "end": 189,
                    "type": "figure",
                    "text": "Figure 5G"
                },
                {
                    "start": 191,
                    "end": 195,
                    "type": "bibr",
                    "ref_id": "b39",
                    "text": "[40]"
                }
            ]
        },
        {
            "text": "Although the allosteric crosstalk between FabZ dimer subunits induced by successive ACP binding could not be observed from the current structure as the crystal was obtained under the condition of saturated ACP binding of FabZ hexamer (ACP:FabZ = 7:1 before gel-filtration purification), the solution-based biophysical results uncovered the existence of such allosteric crosstalk. ",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "Nevertheless, the current structure shows monomer-monomer allosteric crosstalk upon the asymmetric binding of ACP on FabZ dimer subunit, and reveals the dynamic seesaw-like catalytic mechanism of DH FabZ in the FAS system for the first time, which is regulated by the critical gatekeeper residue Tyr100.",
            "section": "Biophysical studies of FabZ-ACP binding"
        },
        {
            "text": "To date, there is little structural information for the interaction of ACP with enzymatic modules in the FAS system, except for an incomplete FabI-ACP structure and the covalently crosslinked FabA-ACP structure [25,29]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 211,
                    "end": 215,
                    "type": "bibr",
                    "ref_id": "b24",
                    "text": "[25,"
                },
                {
                    "start": 215,
                    "end": 218,
                    "type": "bibr",
                    "ref_id": "b28",
                    "text": "29]"
                }
            ]
        },
        {
            "text": "Our study presents the first native high-resolution enzymatic module-ACP complex structure of a FAS system. ",
            "section": "Discussion"
        },
        {
            "text": "The complex exhibits a highly symmetrical FabZ hexamer-ACP 3 stoichiometry with each ACP binding to a FabZ dimer subunit. ",
            "section": "Discussion"
        },
        {
            "text": "Further structural analysis suggests that FabZ contacts ACP through H-bonds between a constellation of conserved Arg/Lys residues near its active tunnel entrance and negatively charged residues along an ACP \u03b12 helix as well as hydrophobic interactions between residues located in the hydrophobic patch near the tunnel entrance of FabZ and residues in the ACP \u03b12 helix. ",
            "section": "Discussion"
        },
        {
            "text": "Remarkably, the conserved Arg110 of FabZ contributes to the FabZ-ACP interactions, suggesting an important role in recognizing and binding of ACP to FabZ. ",
            "section": "Discussion"
        },
        {
            "text": "The binding of ACP to FabZ also induces the movements of the \u03b2-sheet layer, which enlarges the narrow L-shaped active tunnel to a Y-shape for long fatty acid substrate accommodation. ",
            "section": "Discussion"
        },
        {
            "text": "This Y-shaped tunnel has significantly more steric hindrance in reversion of trans-2-acyl-ACP to cis-3-acyl-ACP during isomerization compared with the L-shaped tunnel of FabA, which explains the absence of isomerase activity in FabZ. ",
            "section": "Discussion"
        },
        {
            "text": "More importantly, the movements of the \u03b2-sheet layer not only occur on ACP-bound FabZ monomers but also on ACP-unbound monomers with even larger conformational changes, forming an unfavorable conformation for ACP binding by introducing clashes between FabZ and ACP. ",
            "section": "Discussion"
        },
        {
            "text": "Additional biophysical methods, including SEC-MALS, SAXS and MST, confirmed these observations, and the corresponding binding affinities of ACP toward FabZ were determined. ",
            "section": "Discussion"
        },
        {
            "text": "These findings suggest a novel dynamic seesaw-like continuous catalytic mechanism of DH FabZ with ACP in the FAS-II system, in which ACP's alternate binding is regulated by a FabZ gatekeeper residue Tyr100 through manipulating the movements of FabZ's \u03b2-sheet layer ( Figure 6, and Supplementary information, Movie). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 267,
                    "end": 275,
                    "type": "figure",
                    "text": "Figure 6"
                }
            ]
        },
        {
            "text": "Furthermore, the MST titration result suggests that the binding of ACP to FabZ involves a series of complicated allosteric crosstalk both between monomer subunits and between dimer subunits. ",
            "section": "Discussion"
        },
        {
            "text": "The current crystal structure successfully shows the monomer-monomer crosstalk due to the asymmetric binding of ACP on FabZ dimer subunit. ",
            "section": "Discussion"
        },
        {
            "text": "The current study mainly focuses on the structural changes within a single FabZ dimer subunit as well as the corresponding seesaw-like allosteric crosstalk mechanism on regulating ACP binding; and thus the current structural information is not adequate to explain entire allosteric changes between dimer subunits.",
            "section": "Discussion"
        },
        {
            "text": "The superposition of FabZ-ACP structure, FabA-ACP structure (PDB code: 4KEH) and the mammalian DH module from S. scrofa FASN (PDB code: 2vz8) exhibits high overall structural similarity, indicating that these DH (module) may employ a conserved mechanism to regulate ACP catalysis (Supplementary information, Figure S6A-S6C and S10). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 308,
                    "end": 318,
                    "type": "figure",
                    "text": "Figure S6A"
                }
            ]
        },
        {
            "text": "The major difference among the structures is the numbers of ACP bound to the DH (module). ",
            "section": "Discussion"
        },
        {
            "text": "In FabA-ACP structure case, two ACP mole- Figure 5 Biophysical studies of FabZ-ACP complex in solution. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 42,
                    "end": 50,
                    "type": "figure",
                    "text": "Figure 5"
                }
            ]
        },
        {
            "text": "(A) Size-exclusion chromatography (SEC) coupled with multi-angle light scattering (MALS) analysis. ",
            "section": "Discussion"
        },
        {
            "text": "FabZ protein (black curve) or holo-ACP (blue curve) was separated using a Wyatt Technology WTC-030S5 column. ",
            "section": "Discussion"
        },
        {
            "text": "The running buffer contains 20 mM HEPES (pH 8.0), 500 mM NaCl and 10 mM DTT. ",
            "section": "Discussion"
        },
        {
            "text": "500 mM NaCl, instead of 150 mM NaCl was used due to the instability of FabZ protein in a low-salt buffer. ",
            "section": "Discussion"
        },
        {
            "text": "Corresponding average molecular weight of the fraction peaks marked with stars was evaluated and analyzed using Wyatt Technology SEC-MALS system. ",
            "section": "Discussion"
        },
        {
            "text": "The chromatogram shows the readings of UV detector, and 280 nm absorption scaling is shown in Y axis on the left. ",
            "section": "Discussion"
        },
        {
            "text": "The yellow and green curves indicate the calculated molecular masses of FabZ and holo-ACP throughout the peaks. ",
            "section": "Discussion"
        },
        {
            "text": "The molecular mass scaling is shown in the Y axis on the right. ",
            "section": "Discussion"
        },
        {
            "text": "(B) SEC-MALS analysis of FabZ-ACP complex. ",
            "section": "Discussion"
        },
        {
            "text": "The FabZ-ACP complex saturated with excess amounts of holo-ACP (red curve) was separated using a Wyatt Technology WTC-030S5 column. ",
            "section": "Discussion"
        },
        {
            "text": "The running buffer for separating the complex contains 20 mM HEPES (pH 8.0), 150 mM NaCl and 10 mM DTT. ",
            "section": "Discussion"
        },
        {
            "text": "The magenta curves indicate the calculated molecular masses of FabZ-ACP complex and holo-ACP throughout the peaks. ",
            "section": "Discussion"
        },
        {
            "text": "(C) SAXS scattering data from FabZ-ACP complex in solution. ",
            "section": "Discussion"
        },
        {
            "text": "Curve-1 (black dots): SAXS scattering experimental data. ",
            "section": "Discussion"
        },
        {
            "text": "Curve-2 (red line): scattering pattern calculated from the crystal structure. ",
            "section": "Discussion"
        },
        {
            "text": "Curve-3 (green line): smooth curve back transformed from the p(r) and extrapolated to a zero scattering angle for the complex in solution. ",
            "section": "Discussion"
        },
        {
            "text": "(D) SAXS data analysis: distance distribution functions for the complex. ",
            "section": "Discussion"
        },
        {
            "text": "(E) SAXS modeling: low-resolution envelope for the complex was shown as a particle model and was superposed with the complex crystal structure. ",
            "section": "Discussion"
        },
        {
            "text": "(F) Microscale thermophoresis (MST) measurements of holo-ACP binding to wild-type FabZ. ",
            "section": "Discussion"
        },
        {
            "text": "Data points colored in black, red and blue indicate the differences in normalized fluorescence generated by various concentrations of holo-ACP binding to FabZ. ",
            "section": "Discussion"
        },
        {
            "text": "Curves colored in black, red and green indicate the calculated fits according to the data points, and the corresponding Kd values are shown. ",
            "section": "Discussion"
        },
        {
            "text": "(G) MST measurements of holo-ACP binding to FabZ (Y100A) mutant. ",
            "section": "Discussion"
        },
        {
            "text": "Data points in black indicate the difference in normalized fluorescence generated by various concentrations of holo-ACP binding to FabZ (Y100A). ",
            "section": "Discussion"
        },
        {
            "text": "Curves colored in black indicate the calculated fits according to the data points. ",
            "section": "Discussion"
        },
        {
            "text": "Figure 6 Schematic diagram of the dynamic seesaw-like continuous catalytic mechanism model of FabZ during fatty acid biosynthesis. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 8,
                    "type": "figure",
                    "text": "Figure 6"
                }
            ]
        },
        {
            "text": "Monomers A and B within a FabZ dimer subunit and two ACP molecules are colored in green, light blue, wheat and purple, respectively. ",
            "section": "Discussion"
        },
        {
            "text": "Four critical \u03b2-strands from the \u03b2-sheet layer are shown as oval rafts. ",
            "section": "Discussion"
        },
        {
            "text": "Key gatekeeper residues Tyr100 and Phe83 from FabZ monomer B (cyan) and monomer A (green) are shown as sticks. ",
            "section": "Discussion"
        },
        {
            "text": "The 4\u2032-phosphopantetheine arm (magenta) attached with a long fatty acid chain (orange) from ACP are shown as lines. ",
            "section": "Discussion"
        },
        {
            "text": "In the native conformation of FabZ, the sidechains of Tyr100 and Phe83 adopt close conformation to protect the hydrophobic catalytic tunnel from bulk solvent (step 1). ",
            "section": "Discussion"
        },
        {
            "text": "When the first ACP molecule (wheat) binds to FabZ monomer B, the L-shaped active tunnel is expanded to a Y-shape due to movement of the \u03b2-sheet layer toward 4. ",
            "section": "Discussion"
        },
        {
            "text": "The sidechains of Tyr100 and Phe83 flop ~120\u00b0 to an open conformation, which allows the substrate chain carried by the 4\u2032-Pan-arm to insert into the active tunnel for catalytic dehydration. ",
            "section": "Discussion"
        },
        {
            "text": "Meanwhile, the \u03b2-sheet layer in the ACP-unbound FabZ monomer A moves further toward \u03b24 due to a ~30\u00b0 rotation of the Tyr100 sidechain from its normal closed conformation to form an abnormal conformation unfavorable for ACP binding (purple) (steps 2 and 3). ",
            "section": "Discussion"
        },
        {
            "text": "When the dehydration reaction is finished on monomer B, the \u03b2-sheet layer moves further toward \u03b24 to release ACP, whereas the \u03b2-sheet layer on monomer A moves back with a ~150\u00b0 rotation of the Tyr100 sidechain to a normal open conformation to accept binding and catalysis of the second ACP (steps 4 and 5). ",
            "section": "Discussion"
        },
        {
            "text": "By doing so, the catalysis core is exchanged from FabZ monomer B to monomer A. When the second dehydration reaction is finished, the catalysis core is exchanged to B again like a see-saw due to the movements of the \u03b2-sheet layer (steps 4-6), which causes the high-efficiency catalytic dehydration mechanism of FabZ in the FAS system. ",
            "section": "Discussion"
        },
        {
            "text": "cules bind to a FabA dimer, whereas in our structure, one ACP molecule binds to a FabZ dimer subunit. ",
            "section": "Discussion"
        },
        {
            "text": "This could be caused by the covalent crosslinking of ACP to FabA. ",
            "section": "Discussion"
        },
        {
            "text": "In the DH domain case, it is a pseudo-dimer with distinct differences between the two subdomains, and can only catalyze one ACP at a time rather than two. ",
            "section": "Discussion"
        },
        {
            "text": "However, the DH domain shares a highly structurally conserved \u03b2-sheet layer with FabZ, where ACP molecule binds to, suggesting that the DH domain is very likely to utilize similar mechanism to regulate ACP by manipulating the conformational changes of the \u03b2-sheet layer. ",
            "section": "Discussion"
        },
        {
            "text": "Hence, our finding also contributes to the understanding of mammalian FAS catalytic mechanism, and provides a potential drug discovery strategy against human diseases associated with FAS by inhibiting its enzymatic activity through interfering ACP-enzymatic module interactions. ",
            "section": "Discussion"
        },
        {
            "text": "Collectively, our results illustrate a novel and dynamic ACP binding and regulation mechanism for the DH module in the FAS system, which provides a plausible explanation for previously established phenomenon and facilitates a general understanding of the biological functions of the FAS system.",
            "section": "Discussion"
        },
        {
            "text": "Increasing evidence suggests that overproduction of fatty acids by the FAS system is correlated with MetS and various cancers [12][13][14][15][16][17]41]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 126,
                    "end": 130,
                    "type": "bibr",
                    "ref_id": "b11",
                    "text": "[12]"
                },
                {
                    "start": 130,
                    "end": 134,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "[13]"
                },
                {
                    "start": 134,
                    "end": 138,
                    "type": "bibr",
                    "ref_id": "b13",
                    "text": "[14]"
                },
                {
                    "start": 138,
                    "end": 142,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "[15]"
                },
                {
                    "start": 142,
                    "end": 146,
                    "type": "bibr",
                    "ref_id": "b15",
                    "text": "[16]"
                },
                {
                    "start": 146,
                    "end": 150,
                    "type": "bibr",
                    "ref_id": "b16",
                    "text": "[17]"
                },
                {
                    "start": 150,
                    "end": 153,
                    "type": "bibr",
                    "ref_id": "b40",
                    "text": "41]"
                }
            ]
        },
        {
            "text": "Inhibition of FAS activity significantly induces tumor cell apoptosis, suppresses tumor cell metastasis and improves insulin sensitivity [33,42,43]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 137,
                    "end": 141,
                    "type": "bibr",
                    "ref_id": "b32",
                    "text": "[33,"
                },
                {
                    "start": 141,
                    "end": 144,
                    "type": "bibr",
                    "ref_id": "b41",
                    "text": "42,"
                },
                {
                    "start": 144,
                    "end": 147,
                    "type": "bibr",
                    "ref_id": "b42",
                    "text": "43]"
                }
            ]
        },
        {
            "text": "Hence, hFASN is considered to be a promising anti-MetS and anti-tumor drug target for clinical therapy, and several specific inhibitors for interfering with the enzymatic activity of hFASN have been developed [3,[41][42][43][44][45][46]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 209,
                    "end": 212,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "[3,"
                },
                {
                    "start": 212,
                    "end": 216,
                    "type": "bibr",
                    "ref_id": "b40",
                    "text": "[41]"
                },
                {
                    "start": 216,
                    "end": 220,
                    "type": "bibr",
                    "ref_id": "b41",
                    "text": "[42]"
                },
                {
                    "start": 220,
                    "end": 224,
                    "type": "bibr",
                    "ref_id": "b42",
                    "text": "[43]"
                },
                {
                    "start": 224,
                    "end": 228,
                    "type": "bibr",
                    "ref_id": "b43",
                    "text": "[44]"
                },
                {
                    "start": 228,
                    "end": 232,
                    "type": "bibr",
                    "ref_id": "b44",
                    "text": "[45]"
                },
                {
                    "start": 232,
                    "end": 236,
                    "type": "bibr",
                    "ref_id": "b45",
                    "text": "[46]"
                }
            ]
        },
        {
            "text": "Unfortunately, most of these compounds have limited applications in clinical scenarios due to severe side effects or modest potency [23,33]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 132,
                    "end": 136,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "[23,"
                },
                {
                    "start": 136,
                    "end": 139,
                    "type": "bibr",
                    "ref_id": "b32",
                    "text": "33]"
                }
            ]
        },
        {
            "text": "The dynamic ACP binding and regulation mechanism of the DH module in the FAS system provides a potential novel drug design strategy for interfering with ACP-enzymatic module interactions rather than the enzymatic activities in the FAS system, which may significantly reduce side effects. ",
            "section": "Discussion"
        },
        {
            "text": "Our findings may benefit clinical drug and therapy development against pathogenic infection, as well as human diseases associated with the deregulation of this pathway, including obesity, diabetes, and prostate and breast cancers.",
            "section": "Discussion"
        },
        {
            "text": "Expressions and purifications of apo-ACP, holo-ACP, FabZ and FabZ (Y100A) from H. pylori were expressed and purified as described previously [36,37]. ",
            "section": "Protein subcloning, expression and purification",
            "ref_spans": [
                {
                    "start": 141,
                    "end": 145,
                    "type": "bibr",
                    "ref_id": "b35",
                    "text": "[36,"
                },
                {
                    "start": 145,
                    "end": 148,
                    "type": "bibr",
                    "ref_id": "b36",
                    "text": "37]"
                }
            ]
        },
        {
            "text": "Briefly, FabZ gene was subcloned to PQE30 plasmid and expressed in Escherichia coli strain M15 cells. ",
            "section": "Protein subcloning, expression and purification"
        },
        {
            "text": "QuikChange Site-Directed Mutagenesis (Stratagene) strategy was used to perform the FabZ (Y100A) mutagenesis. ",
            "section": "Protein subcloning, expression and purification"
        },
        {
            "text": "FabZ and FabZ (Y100A) protein were purified by using Ni-NTA and Gel-filtration column. ",
            "section": "Protein subcloning, expression and purification"
        },
        {
            "text": "ACP gene was subcloned to pET32a vector and expressed in E. coli BL21 cells. ",
            "section": "Protein subcloning, expression and purification"
        },
        {
            "text": "The protein was purified by using Ni-NTA, and the N-terminal thioredoxin-His tag was removed by recombinant enterokinase protease cleavage at 4 \u00b0C for overnight. ",
            "section": "Protein subcloning, expression and purification"
        },
        {
            "text": "Subsequently, ACP protein was further purified by GE HiLoad 16/600 Superdex 75 prep grade gel-filtration column. ",
            "section": "Protein subcloning, expression and purification"
        },
        {
            "text": "The final concentration was quantified by Bradford reagent purchased from Bio-Rad. ",
            "section": "Protein subcloning, expression and purification"
        },
        {
            "text": "For the FabZ-holo-ACP complex, the purified FabZ and holo-ACP protein were mixed in molar ratio 1:7, and dialyzed against 20 mM HEPES, pH 8.0, 150 mM NaCl and 10 mM DTT. ",
            "section": "Protein subcloning, expression and purification"
        },
        {
            "text": "The mixture was concentrated and loaded to HiLoad 16/600 Superdex 200 prep grade column for further purification. ",
            "section": "Protein subcloning, expression and purification"
        },
        {
            "text": "The complex peak was pooled and concentrated to10 mg/ml.",
            "section": "Protein subcloning, expression and purification"
        },
        {
            "text": "Approximately 10 mg/ml apo-ACP, holo-ACP and complex protein were mixed with an equal volume of reservoir solution containing 1.0-3.0 M sodium chloride and 0.1 M sodium acetate, and 1.0-3.0 M lithium sulfate and 0.5 M ammonium sulfate, and 10%-30% PEG3350, 0.05 M tri-sodium citrate dehydrate, respectively, and equilibrated against 500 \u00b5l of the reservoir solution at 277 K. Crystals appeared within 30 days. ",
            "section": "Apo-ACP, holo-ACP and FabZ-ACP complex crystallization"
        },
        {
            "text": "The crystals were then flash-frozen in liquid nitrogen with 20%-30% glycerol (v/v) as the cryoprotectant solution.",
            "section": "Apo-ACP, holo-ACP and FabZ-ACP complex crystallization"
        },
        {
            "text": "Crystal diffraction data of apo-ACP and FabZ-ACP complex were collected at beamline BL19U1 at the National Center for Protein Sciences Shanghai and Shanghai Synchrotron Radiation Facility, China. ",
            "section": "Data collection and structure determination"
        },
        {
            "text": "Significant decay of the complex crystals during data collection caused the resolution cut off at 2.55 \u00c5. ",
            "section": "Data collection and structure determination"
        },
        {
            "text": "While the crystal diffraction data of holo-ACP were collected at 100 K using CuK\u03b1 X-ray with a Rigaku R-AXIS IV++ image plate. ",
            "section": "Data collection and structure determination"
        },
        {
            "text": "The data were further processed using HKL2000 software package [47] and CrystalClear software. ",
            "section": "Data collection and structure determination",
            "ref_spans": [
                {
                    "start": 63,
                    "end": 67,
                    "type": "bibr",
                    "text": "[47]"
                }
            ],
            "entity_spans": [
                {
                    "start": 38,
                    "end": 45,
                    "type": "software",
                    "rawForm": "HKL2000",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-0"
                },
                {
                    "start": 72,
                    "end": 84,
                    "type": "software",
                    "rawForm": "CrystalClear",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-1"
                }
            ]
        },
        {
            "text": "The structures were solved by MR with the published structure of apo-EcACP (PDB code: 1T8K) and HpFabZ (PDB code: 2GLL) as search models, and refined by using programs Phenix [48] (complex) and CNS (apo and holo-ACP). ",
            "section": "Data collection and structure determination",
            "ref_spans": [
                {
                    "start": 175,
                    "end": 179,
                    "type": "bibr",
                    "text": "[48]"
                }
            ],
            "entity_spans": [
                {
                    "start": 168,
                    "end": 174,
                    "type": "software",
                    "rawForm": "Phenix",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-2"
                },
                {
                    "start": 194,
                    "end": 197,
                    "type": "software",
                    "rawForm": "CNS",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-3"
                }
            ]
        },
        {
            "text": "The crystallographic statistics are summarized in Supplementary information, Table S1. ",
            "section": "Data collection and structure determination",
            "ref_spans": [
                {
                    "start": 77,
                    "end": 84,
                    "type": "table",
                    "text": "Table S"
                }
            ]
        },
        {
            "text": "Electron density interpretation and model building were performed using the computer graphics program Coot [49]. ",
            "section": "Data collection and structure determination",
            "ref_spans": [
                {
                    "start": 107,
                    "end": 111,
                    "type": "bibr",
                    "text": "[49]"
                }
            ],
            "entity_spans": [
                {
                    "start": 102,
                    "end": 106,
                    "type": "software",
                    "rawForm": "Coot",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-4"
                }
            ]
        },
        {
            "text": "Final structures were visualized by PyMol software.",
            "section": "Data collection and structure determination",
            "entity_spans": [
                {
                    "start": 36,
                    "end": 41,
                    "type": "software",
                    "rawForm": "PyMol",
                    "resp": "#curator",
                    "used": true,
                    "id": "a675de2da1-software-simple-5"
                }
            ]
        },
        {
            "text": "SYBYL package (www.tripos.com) was used to prepare the fatty acid chains and the protein structures used in docking. ",
            "section": "Covalent docking"
        },
        {
            "text": "Initial structures of fatty acid chains in different lengths (4-to 16-carbon chain) were sketched using the SYBYL program with standard geometric parameters, and Gasteiger-Hucker charge was added. ",
            "section": "Covalent docking"
        },
        {
            "text": "All fatty acids were then optimized using the standard TRIPOS force field with Gasteiger-H\u00fcckel charges until the energy gradient converged to below 0.05 kcal/mol. ",
            "section": "Covalent docking"
        },
        {
            "text": "Waters in the crystal structure of FabZ were removed, and all hydrogens were added. ",
            "section": "Covalent docking"
        },
        {
            "text": "Kollman all-atom charges were assigned for FabZ and Gasteiger-H\u00fcckel charge was computed for residue 36 with 4\u2032-Pan-arm.",
            "section": "Covalent docking"
        },
        {
            "text": "Genetic algorithm-based docking program GOLD was used for molecular docking simulations [50]. ",
            "section": "Covalent docking",
            "ref_spans": [
                {
                    "start": 88,
                    "end": 92,
                    "type": "bibr",
                    "text": "[50]"
                }
            ],
            "entity_spans": [
                {
                    "start": 40,
                    "end": 44,
                    "type": "software",
                    "rawForm": "GOLD",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-9"
                }
            ]
        },
        {
            "text": "Fatty acid chain-binding site for docking was defined as a collection of all atoms within 25 \u00c5 around the midpoint of the terminal S of the 4-Pan-arm and O atom of Lys97, so the active site would be big enough to include the possible binding sites of variable length fatty acid chains. ",
            "section": "Covalent docking"
        },
        {
            "text": "The GOLDScore fitness function was employed in scoring conformations. ",
            "section": "Covalent docking"
        },
        {
            "text": "The parameters for GOLD were as follows: numbers of GA ran 50, no early termination was allowed and all other parameters were used as default (Supplementary information, Table S3).",
            "section": "Covalent docking",
            "ref_spans": [
                {
                    "start": 170,
                    "end": 179,
                    "type": "table",
                    "text": "Table S3)"
                }
            ]
        },
        {
            "text": "Approximately 10 \u00b5l, 0.5 mg/ml purified FabZ-ACP complex saturated with excess amount of holo-ACP sample was injected into HPLC system (Agilent Technologies) and separated by using Wyatt Technology WTC-030S5 column with running buffer containing 20 mM HEPES, pH 8.0, 150 mM NaCl and 10 mM DTT. ",
            "section": "Size-exclusion chromatography coupled with multi-angle light scattering measurements"
        },
        {
            "text": "The native FabZ or holo-ACP protein was separated with running buffer containing 20 mM HEPES, pH 8.0, 500 mM NaCl and 10 mM DTT due to the instability of FabZ protein under low salt (150 mM NaCl) buffer. ",
            "section": "Size-exclusion chromatography coupled with multi-angle light scattering measurements"
        },
        {
            "text": "Corresponding molecular weight of the fraction peaks was evaluated and analyzed by using Wyatt Technology SEC-MALS system, which was calibrated by using 2 mg/ml standard BSA sample. ",
            "section": "Size-exclusion chromatography coupled with multi-angle light scattering measurements"
        },
        {
            "text": "As shown in Figure 5A and 5B, FabZ-ACP MW calculated = 145 KDa, MW observed = 143 (\u00b1 2.0%) kDa; FabZ MW calculated = 117 kDa, MW observed = 112.7 (\u00b1 0.66%) kDa; holo-ACP MW calculated = 9382 Da, MW observed = 9331 (\u00b1 4.3%) Da.",
            "section": "Size-exclusion chromatography coupled with multi-angle light scattering measurements",
            "ref_spans": [
                {
                    "start": 12,
                    "end": 21,
                    "type": "figure",
                    "text": "Figure 5A"
                }
            ]
        },
        {
            "text": "FabZ-ACP complex purified from gel-filtration in the solution containing 20 mM HEPES, pH 8.0, 150 mM NaCl and 10 mM DTT was used in the Synchrotron SAXS experiment. ",
            "section": "Synchrotron solution small angle X-ray scattering measurements"
        },
        {
            "text": "The measurement was performed in a vacuum cuvette with exposure time of 1 s to diminish the parasitic scattering under wavelength 1.03 \u00c5 at National Center for Protein Sciences Shanghai (NCPSS) beamline BL19U2, China. ",
            "section": "Synchrotron solution small angle X-ray scattering measurements"
        },
        {
            "text": "The scattering was recorded in the range of the momentum transfer 0.015 < s < 0.420/\u00c5, where s = (4\u03c0 \u00d7 sin\u03b8)/\u03bb and 2\u03b8 is the scattering angle. ",
            "section": "Synchrotron solution small angle X-ray scattering measurements"
        },
        {
            "text": "SAXS data were subsequently processed and analyzed by using the ATSAS program suite [51]. ",
            "section": "Synchrotron solution small angle X-ray scattering measurements",
            "ref_spans": [
                {
                    "start": 84,
                    "end": 88,
                    "type": "bibr",
                    "text": "[51]"
                }
            ],
            "entity_spans": [
                {
                    "start": 64,
                    "end": 69,
                    "type": "software",
                    "rawForm": "ATSAS",
                    "resp": "#annotator3",
                    "id": "a675de2da1-software-simple-10"
                }
            ]
        },
        {
            "text": "Briefly, program PRIMUS [52] was employed to process the experimental scattering data and correct the solvent background scattering. ",
            "section": "Synchrotron solution small angle X-ray scattering measurements",
            "ref_spans": [
                {
                    "start": 24,
                    "end": 28,
                    "type": "bibr",
                    "text": "[52]"
                }
            ],
            "entity_spans": [
                {
                    "start": 17,
                    "end": 23,
                    "type": "software",
                    "rawForm": "PRIMUS",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-11"
                }
            ]
        },
        {
            "text": "Program CRYSOL was used to generate the theoretical scattering from the FabZ-ACP complex crystal structure [53]. ",
            "section": "Synchrotron solution small angle X-ray scattering measurements",
            "ref_spans": [
                {
                    "start": 107,
                    "end": 111,
                    "type": "bibr",
                    "text": "[53]"
                }
            ],
            "entity_spans": [
                {
                    "start": 8,
                    "end": 14,
                    "type": "software",
                    "rawForm": "CRYSOL",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-12"
                }
            ]
        },
        {
            "text": "Program GNOM was employed to calculate the distance distribution function p(r) (Figure 5C and 5D) [54]. ",
            "section": "Synchrotron solution small angle X-ray scattering measurements",
            "ref_spans": [
                {
                    "start": 98,
                    "end": 102,
                    "type": "bibr",
                    "text": "[54]"
                }
            ],
            "entity_spans": [
                {
                    "start": 8,
                    "end": 12,
                    "type": "software",
                    "rawForm": "GNOM",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-13"
                }
            ]
        },
        {
            "text": "Subsequently, programsDAMMIN [55], GASBOR [56] and DAMAVER [57] were used to reconstruct the low-resolution shapes to a dummy atom particle model, and superpose to the crystal structure (Figure 5E). ",
            "section": "Synchrotron solution small angle X-ray scattering measurements",
            "ref_spans": [
                {
                    "start": 29,
                    "end": 33,
                    "type": "bibr",
                    "text": "[55]"
                },
                {
                    "start": 42,
                    "end": 46,
                    "type": "bibr",
                    "text": "[56]"
                },
                {
                    "start": 59,
                    "end": 63,
                    "type": "bibr",
                    "text": "[57]"
                }
            ],
            "entity_spans": [
                {
                    "start": 22,
                    "end": 28,
                    "type": "software",
                    "rawForm": "DAMMIN",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-14"
                },
                {
                    "start": 35,
                    "end": 41,
                    "type": "software",
                    "rawForm": "GASBOR",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-15"
                },
                {
                    "start": 51,
                    "end": 58,
                    "type": "software",
                    "rawForm": "DAMAVER",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-16"
                }
            ]
        },
        {
            "text": "The figure was generated by using GraphPad Prism 5 and PyMol software.",
            "section": "Synchrotron solution small angle X-ray scattering measurements",
            "entity_spans": [
                {
                    "start": 34,
                    "end": 48,
                    "type": "software",
                    "rawForm": "GraphPad Prism",
                    "resp": "#curator",
                    "id": "a675de2da1-software-26"
                },
                {
                    "start": 49,
                    "end": 50,
                    "type": "version",
                    "rawForm": "5",
                    "resp": "#annotator3",
                    "id": "#a675de2da1-software-26"
                },
                {
                    "start": 55,
                    "end": 60,
                    "type": "software",
                    "rawForm": "PyMol",
                    "resp": "#annotator3",
                    "used": true,
                    "id": "a675de2da1-software-simple-19"
                }
            ]
        },
        {
            "text": "MST assay is a new immobilization-free and titration-based technology for biomolecule interaction determination [58]. ",
            "section": "Microscale thermophoresis assays",
            "ref_spans": [
                {
                    "start": 112,
                    "end": 116,
                    "type": "bibr",
                    "text": "[58]"
                }
            ]
        },
        {
            "text": "The assay was performed with a NanoTemper Monolith NT.115 instrument (NanoTemper Technologies GmbH). ",
            "section": "Microscale thermophoresis assays"
        },
        {
            "text": "Briefly, FabZ or FabZ (Y100A) was labeled with fluorescence dye NT-647 (amine-reaction) according to manufacturer's protocol. ",
            "section": "Microscale thermophoresis assays"
        },
        {
            "text": "Subsequently, 50 nM of labeled protein was mixed with various concentrations of holo-ACP in the reaction buffer containing 20 mM HEPES, pH 8.0, 150 mM NaCl, 5 mM fresh DTT and 0.05% Tween 20. ",
            "section": "Microscale thermophoresis assays"
        },
        {
            "text": "After incubation for 5 min under room temperature, 10 \u00b5l of the mixtures were loaded into premium coated capillaries for measurement. ",
            "section": "Microscale thermophoresis assays"
        },
        {
            "text": "The MST data were then collected under 40% infrared laser power and 20% light-emitting diode power. ",
            "section": "Microscale thermophoresis assays"
        },
        {
            "text": "Nanotemper analysis software (1.5.41) was used to fit the independent experimental data and determine Kd and standard deviation value. ",
            "section": "Microscale thermophoresis assays"
        },
        {
            "text": "The figure was generated by using GraphPad Prism 5.",
            "section": "Microscale thermophoresis assays",
            "entity_spans": [
                {
                    "start": 34,
                    "end": 48,
                    "type": "software",
                    "rawForm": "GraphPad Prism",
                    "resp": "#curator",
                    "id": "a675de2da1-software-29"
                },
                {
                    "start": 49,
                    "end": 50,
                    "type": "version",
                    "rawForm": "5",
                    "resp": "#annotator3",
                    "id": "#a675de2da1-software-29"
                }
            ]
        },
        {
            "text": "This project was supported by the National Natural Science Foundation of China (21572133 to LZ, 21210003 to HJ and 91413102 to XS), the Program for Professors of Special Appointment (Eastern Scholar) at the Shanghai Institutions of Higher Learning (to LZ), the National Great Basic Science Project of China (2010CB529806 to HC), the Ministry of Science and Technology of China (2015CB910304 to HJ). ",
            "section": "Acknowledgments"
        },
        {
            "text": "We thank the staff of beamlines BL19U1 and BL19U2 at the National Center for Protein Sciences Shanghai (NCPSS) and Shanghai Synchrotron Radiation Facility (SSRF, China) for assistance with crystal diffraction and SAXS data collection. ",
            "section": "Acknowledgments"
        },
        {
            "text": "We thank professors Jianping Ding and Jiamu Du from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences for data analysis and discussion. ",
            "section": "Acknowledgments"
        },
        {
            "text": "We thank Mr Jing Lan from WYATT Technology for SEC-MALS technical support, Mr Fenfei Wang from Quantum Design China & Nano-Temper Technologies GmbH for MST technical support, and Dr Jos\u00e9 Ram\u00f3n Andrade Candelario for production of the animation (http://www.3dciencia.com/).",
            "section": "Acknowledgments"
        },
        {
            "text": "HJ and LZ designed the experiments; LZ, TRF and ZWC performed protein purification; LZ and LZ performed the crystallization as well as SEC-MALS, SAXS and the MST biophysical experiments; JFX and JRX performed the computational analysis; HJ, LZ, LZ and JFX wrote the paper. ",
            "section": "Author Contributions"
        },
        {
            "text": "All authors discussed and commented on the manuscript.",
            "section": "Author Contributions"
        },
        {
            "text": "The authors declare no competing financial interests.",
            "section": "Competing Financial Interests"
        }
    ]
}